Hi Sanjee,
This topic is certainly relevant to our community. ARv7 is a traditional target that presents significant challenges in reagent generation and ligandability. Developing a degrader approach for this target is quite difficult. Would you be willing to share your insights in a forum post, or would you prefer to present them at one of our Science Circle Meetings?
Best wishes,
Markus
------------------------------
Markus Queisser
Scientific Director
GlaxoSmithKline
Stevenage
441438764034
------------------------------
Original Message:
Sent: 05-14-2025 12:23 PM
From: Sanjee Tawde
Subject: Molecular glues (TPD)
Interested in learning more about Degrader screen for Androgen Receptor variant 7?
------------------------------
Sanjee Tawde
Assay Works GmbH
Regensburg
004915122850276
------------------------------